share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4：持股变动声明-高管 Dogan Meeshanthini
美股SEC公告 ·  2024/09/09 08:10

Moomoo AI 已提取核心信息

Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. (CDIO)报告称，其首席技术官Dogan Meeshanthini于2024年9月6日完成了对公司股票的购买。该交易涉及以0.29美元的价格收购68965股普通股。在此交易之后，Meeshanthini在公司的直接持股增加至总共197310股。这次在公开市场上进行的购买反映了公司高管对公司前景的信心。
Cardio Diagnostics Holdings, Inc. (CDIO)报告称，其首席技术官Dogan Meeshanthini于2024年9月6日完成了对公司股票的购买。该交易涉及以0.29美元的价格收购68965股普通股。在此交易之后，Meeshanthini在公司的直接持股增加至总共197310股。这次在公开市场上进行的购买反映了公司高管对公司前景的信心。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间